Sign in Register

Drug class

Injectable Antihypertensive Agents,Nitric Oxide/cGMP pathway

The phrase "Injectable Antihypertensive Agents,Nitric Oxide/cGMP pathway" is not a formal standalone regulatory drug class established by the FDA, but rather a functional classification combining parenteral blood-pressure-lowering medications with their underlying molecular mechanism. Read more about Injectable Antihypertensive Agents,Nitric Oxide/cGMP pathway

26 drugs in this class 22 manufacturers

Related classes & indications

Calcium Channel BlockersCardiovascular & renal · 344 prescription drugs Angiotensin II Receptor Antagonists (ARBs)Cardiovascular & renal · 281 prescription drugs Pulmonary Arterial HypertensionTop indication · 135 prescription drugs

Showing 19–26 of 26 drugs

Sort

SODIUM NITROPRUSSIDE (nitroprusside sodium)

NITROPRUSSIDE SODIUM · HYPERTENSIVE CRISIS ·+2

BE PHARMACEUTIC

SODIUM NITROPRUSSIDE (nitroprusside sodium)

NITROPRUSSIDE SODIUM · HYPERTENSIVE CRISIS ·+2

ARMAS PHARMACEU

SODIUM NITROPRUSSIDE (nitroprusside sodium)

NITROPRUSSIDE SODIUM · HYPERTENSIVE CRISIS ·+2

ARMAS-NOVAPLUS

SODIUM NITROPRUSSIDE (nitroprusside sodium)

NITROPRUSSIDE SODIUM · HYPERTENSIVE CRISIS ·+2

MYLAN INSTITUTI

REVATIO (sildenafil citrate)

AGENTS TO TREAT ERECTILE DYSFUNCTION, CGMP-TYPE · PULMONARY ARTERIAL HYPERTENSION

VIATRIS SPECIAL

SODIUM NITROPRUSSIDE (nitroprusside sodium)

NITROPRUSSIDE SODIUM · HYPERTENSIVE CRISIS ·+2

CAPLIN STERILES

SODIUM NITROPRUSSIDE (nitroprusside sodium)

NITROPRUSSIDE SODIUM · HYPERTENSIVE CRISIS ·+2

DR. REDDY'S/PRE

NITROGLYCERIN

NITRATES · PERIOPERATIVE HYPERTENSION ·+3

REMEDYREPACK, I

Filter & compare in the drug finder → Opens the drug finder with Injectable Antihypertensive Agents,Nitric Oxide/cGMP pathway preselected. Add indication or manufacturer filters there.

About Injectable Antihypertensive Agents,Nitric Oxide/cGMP pathway.

The phrase "Injectable Antihypertensive Agents,Nitric Oxide/cGMP pathway" is not a formal standalone regulatory drug class established by the FDA, but rather a functional classification combining parenteral blood-pressure-lowering medications with their underlying molecular mechanism.

Medications within this descriptive category, such as intravenous sodium nitroprusside and nitroglycerin, deliver or release exogenous nitric oxide to stimulate soluble guanylate cyclase in vascular smooth muscle.

This activation increases intracellular cyclic guanosine monophosphate (cGMP), triggering calcium reduction, vascular relaxation, and rapid vasodilation of arterial and venous beds.

Clinically, these parenteral agents are utilized for acute blood pressure control in acute hypertensive crises, perioperative hypotension induction, and acute decompensated heart failure.

fda.gov
The phrase "Injectable Antihypertensive Agents,Nitric Oxide/cGMP pathway" is not a formal standalone regulatory drug class established by the FDA, but rather a functional classification combining parenteral blood-pressure-lowering medications with their underlying molecular mechanism
fda.gov
The phrase "Injectable Antihypertensive Agents,Nitric Oxide/cGMP pathway" is not a formal standalone regulatory drug class established by the FDA, but rather a functional classification combining parenteral blood-pressure-lowering medications with their underlying molecular mechanism Medications within this descriptive category, such as intravenous sodium nitroprusside and nitroglycerin, deliver or release exogenous nitric oxide to stimulate soluble guanylate cyclase in vascular smooth muscle Th...
nih.gov
The phrase "Injectable Antihypertensive Agents,Nitric Oxide/cGMP pathway" is not a formal standalone regulatory drug class established by the FDA, but rather a functional classification combining parenteral blood-pressure-lowering medications with their underlying molecular mechanism Medications within this descriptive category, such as intravenous sodium nitroprusside and nitroglycerin, deliver or release exogenous nitric oxide to stimulate soluble guanylate cyclase in vascular smooth muscle Th...
inrae.fr
Medications within this descriptive category, such as intravenous sodium nitroprusside and nitroglycerin, deliver or release exogenous nitric oxide to stimulate soluble guanylate cyclase in vascular smooth muscle